Register to leave comments

  • News bot Jan. 29, 2026, 2:16 p.m.

    🔍 Powl Brian T. (Executive)

    Company: Kura Oncology, Inc. (KURA)

    Report Date: 2026-01-27

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 6,414

    Detailed Transactions and Holdings:

    • Sold 4,842 shares of Common Stock at $8.4606 per share (Direct)
      Date: 2026-01-27 | Code: S | equity_swap_involved: false | shares_owned_after: 184,847.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,572 shares of Common Stock at $8.4607 per share (Direct)
      Date: 2026-01-27 | Code: S | equity_swap_involved: false | shares_owned_after: 183,275.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25.
    • F2: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.